Patent US4493892A successfully refreshed from Google Patents.
US4493892A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations
Assignee: Memorial Sloan Kettering Cancer Center
•
Filing: 1982-12-20
•
Granted: 1985-01-15
•
Expires: 2002-12-20
Abstract
Abstract A process and reagent for determining the presence of fecal occult blood in a test sample using a guaiac-peroxidase test matrix and a means for inhibiting peroxidase enzyme interferences which combines the partial denaturing of peroxidase enzyme protein using a protein-hydrogen bond cleaving agent, with the removal of metals necessary for efficient peroxidase enzyme activity wherein the improvement comprises dissolving said reagent for cleaving protein-hydrogen bonds in an alcohol-water solvent before adding said reagent to the sample.
Inventors
- 👤 Martin Fleisher
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 09:48
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/725
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
93 words
In a process for determining the presence of fecal occult blood in a test sample which comprises inhibiting peroxidase enzyme interferences by partially denaturing the peroxidase enzyme protein using a protein-hydrogen bond cleaving agent, and simultaneously removing metals necessary for efficient peroxidase enzyme activity, and thereafter using a guaiac-peroxidase test matrix to determine fecal occult blood; the improvement comprising dissolving said protein-hydrogen bond cleaving agent in an alcohol-water solvent formed of approximately 20 to 50% by volume of methanol, ethanol, isopropanol or n-butanol in water; and thereafter adding said agent to the sample.
Claim 2
Dependent Claim
93 words
In a process for determining the presence of fecal occult blood in a test sample which comprises inhibiting peroxidase enzyme interferences by partially denaturing the peroxidase enzyme protein using a protein-hydrogen bond cleaving agent, and simultaneously removing metals necessary for efficient peroxidase enzyme activity, and thereafter using a guaiac-peroxidase test matrix to determine fecal occult blood; the improvement comprising dissolving said protein-hydrogen bond cleaving agent in an alcohol-water solvent formed of approximately 20 to 50% by volume of methanol, ethanol, isopropanol or n-butanol in water; and thereafter adding said agent to the sample.
Claim 3
Dependent Claim
31 words
The process of claim 1 further comprising the step of adding weak acid having an acid strength approximately the same as acetic acid, to the reaction mixture before developing the color.
Claim 4
Dependent Claim
11 words
The process of claim 2 wherein the acid is acetic acid.
Claim 5
Dependent Claim
15 words
The process of claim 2 wherein 2 drops of acid are added to the sample.
Claim 6
Dependent Claim
14 words
The process of claim 1 wherein said reagent is guanidine, urea, or salicylic acid.
Claim 7
Dependent Claim
17 words
The process of claim 1 wherein said alcohol-water solvent comprises about equal volumes of water and alcohol.
Claim 8
Dependent Claim
13 words
The process of claim 6 wherein the reagent solution comprises 6M guanidine hydrochloride.
Claim 9
Dependent Claim
101 words
In a process for determining the presence of fecal occult blood in a test sample which comprises inhibiting peroxidase enzyme interferences by partially denaturing the peroxidase enzyme protein using protein-hydrogen bond cleaving agent, and simultaneously removing metals necessary for efficient peroxidase enzyme activity, and thereafter using a guaiac-peroxidase test matrix to determine fecal occult blood by the development of a blue color based on the phenolic oxidation of guaiac by hemoglobin in the presence of hydrogen peroxide, the improvement comprising adding a weak acid having an acid strength approximately the same as acetic acid to the reaction before developing the color.
Claim 10
Dependent Claim
101 words
In a process for determining the presence of fecal occult blood in a test sample which comprises inhibiting peroxidase enzyme interferences by partially denaturing the peroxidase enzyme protein using protein-hydrogen bond cleaving agent, and simultaneously removing metals necessary for efficient peroxidase enzyme activity, and thereafter using a guaiac-peroxidase test matrix to determine fecal occult blood by the development of a blue color based on the phenolic oxidation of guaiac by hemoglobin in the presence of hydrogen peroxide, the improvement comprising adding a weak acid having an acid strength approximately the same as acetic acid to the reaction before developing the color.
Claim 11
Dependent Claim
21 words
The process of claim 8 wherein the mild acid is added before the reagent for cleaving protein hydrogen bonds is added.
Claim 12
Dependent Claim
11 words
The process of claim 8 wherein the acid is acetic acid.
Claim 13
Dependent Claim
12 words
The process of claim 10 wherein two drops of acid are added.
Claim 14
Dependent Claim
12 words
The process of claim 9 wherein two drops of acid are added.
Claim 15
Dependent Claim
46 words
A reagent for inhibiting peroxidase enzyme interference in the process for fecal occult blood determination of claim 1 comprising an effective amount of guanidine, urea or salicylic acid and EDTA dissolved in the alcohol-water solvent having a 20 to 50% by volume alcohol in water solution.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-01-15 | 1988-07-16 | 1989-01-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-01-15 | 1992-07-16 | 1993-01-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-01-15 | 1996-07-16 | 1997-01-15 | $7700.00 | Window Closed / Lapsed |